Expressions of cyclin B1 and p21cipl in adult acute leukemia and their correlation.
- Author:
Wei-Dong MA
1
;
Shi-Rong XU
;
Yun-Li YAN
;
Xiao-Nan GUO
;
Shu-Kai QIAO
;
Fang XUE
;
Xiao-Li GAO
Author Information
1. Department of Hematology, The Second Hosptial, Hebei Medical University, Shijiazhuang 050000, China.
- Publication Type:Journal Article
- MeSH:
Acute Disease;
Adolescent;
Adult;
Aged;
Cell Proliferation;
Cyclin B;
genetics;
Cyclin B1;
Cyclin-Dependent Kinase Inhibitor p21;
genetics;
Female;
HL-60 Cells;
Humans;
Kaplan-Meier Estimate;
Leukemia;
drug therapy;
genetics;
pathology;
Male;
Middle Aged;
Neoplasm Recurrence, Local;
Prognosis;
Proliferating Cell Nuclear Antigen;
genetics;
RNA, Messenger;
biosynthesis;
genetics;
metabolism;
Reverse Transcriptase Polymerase Chain Reaction
- From:
Journal of Experimental Hematology
2005;13(5):751-758
- CountryChina
- Language:English
-
Abstract:
Cyclin B1, a positive regulator, controls mitosis occurrence, plays an important role in cell proliferation. To investigate the clinical significance of cyclin B1, the expression of cyclin B1 in acute leukemia (AL) patients was measured; the expression of cyclin B1 and p21(cipl), and their cell cycle distribution were assayed by flow cytometry in 136 adult patients with newly diagnosed AL, 10 continuous complete remission (CCR) AL and 17 normal controls; the mRNA of cyclin B1 and p21(cipl), and the proliferation cell nuclear antigen (PCNA) in patients and normal controls were detected with semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). The results showed that the expression of cyclin B1 in newly diagnosed AL patients was significantly higher than that in normal controls. For the relapsed AL patients, the cyclin B1 expression was also higher than that in normal controls, but lower than that in newly diagnosed cases, there was no significant difference between the remission cases and normal controls, nor difference between CCR AL patients and normal controls. All patients with high cyclin B1 expression had an unscheduled expression manner, that cyclin B1 protein appeared in G(1) phase, and in some case it even higher than that of G(2) phase. The response rate (partial remission + complete remission) and survival rate in the cyclin B1 high expressed patients were higher than that of cyclin B1 low expressed patients. The relapse rate in cyclin B1 high expressed patients was higher than that in cyclin B1 normally expressed patients. The survival rate in cyclin B1 high expressed patients was higher than that in cyclin B1 low expression patients. A negative correlation between the expression of cyclin B1 and p21(cipl) was observed. Additionally, cyclin B1 protein expression was generally correlated with proliferation index (PI) and proliferation cell nuclear antigen (PCNA). It is concluded that this study demonstrates for the first time cyclin B1 overexpression and abnormally distribution in cell cyclin of newly diagnosed AL patients. It was considered that cyclin B1 may play an important role in leukemic pathogeneses and can be one of the factors influencing the prognosis of AL patients.
